Insider Transactions in Q1 2021 at Quanterix Corp (QTRX)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 19
2021
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
1,667
-4.17%
|
$96,686
$58.36 P/Share
|
|
Mar 16
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.25%
|
$300,000
$60.96 P/Share
|
|
Mar 08
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.13%
|
$330,000
$66.46 P/Share
|
|
Mar 01
2021
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
137
-0.28%
|
$11,097
$81.55 P/Share
|
|
Mar 01
2021
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
202
-0.29%
|
$16,362
$81.55 P/Share
|
|
Mar 01
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
3,443
-0.17%
|
$278,883
$81.55 P/Share
|
|
Mar 01
2021
|
Amol Chaubal Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
166
-0.27%
|
$13,446
$81.55 P/Share
|
|
Mar 01
2021
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
217
-0.32%
|
$17,577
$81.55 P/Share
|
|
Feb 19
2021
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
871
-0.64%
|
$77,519
$89.96 P/Share
|
|
Feb 19
2021
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
871
-0.62%
|
$77,519
$89.96 P/Share
|
|
Feb 19
2021
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
670
-0.67%
|
$59,630
$89.96 P/Share
|
|
Feb 19
2021
|
Amol Chaubal Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
733
-0.59%
|
$65,237
$89.96 P/Share
|
|
Feb 19
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
3,493
-0.09%
|
$310,877
$89.96 P/Share
|
|
Feb 18
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.25%
|
$420,000
$84.49 P/Share
|
|
Feb 11
2021
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
1,667
-4.01%
|
$131,693
$79.62 P/Share
|
|
Feb 09
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.16%
|
$385,000
$77.95 P/Share
|
|
Feb 08
2021
|
Dawn Mattoon Sr. VP, Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
3,679
+9.63%
|
-
|
|
Feb 08
2021
|
Mark T. Roskey SVP, Strategic Partnerships |
BUY
Grant, award, or other acquisition
|
Direct |
3,373
+11.84%
|
-
|
|
Feb 08
2021
|
John J Fry General Counsel & Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
3,679
+9.41%
|
-
|
|
Feb 08
2021
|
Amol Chaubal Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,789
+15.67%
|
-
|
|
Feb 08
2021
|
William Geist Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,906
+9.84%
|
-
|
|
Feb 08
2021
|
David C. Duffy SVP R&D and CTO |
BUY
Grant, award, or other acquisition
|
Direct |
2,146
+4.9%
|
-
|
|
Feb 08
2021
|
E Kevin Hrusovsky Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
18,397
+1.78%
|
-
|
|
Feb 01
2021
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
105
-0.24%
|
$7,140
$68.21 P/Share
|
|
Feb 01
2021
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
163
-0.26%
|
$11,084
$68.21 P/Share
|
|
Feb 01
2021
|
Amol Chaubal Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
133
-0.26%
|
$9,044
$68.21 P/Share
|
|
Feb 01
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
8,249
-0.16%
|
$544,434
$66.71 P/Share
|
|
Feb 01
2021
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
182
-0.29%
|
$12,376
$68.21 P/Share
|
|
Jan 25
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.25%
|
$385,000
$77.92 P/Share
|
|
Jan 22
2021
|
David C. Duffy SVP R&D and CTO |
SELL
Open market or private sale
|
Direct |
1,667
-4.05%
|
$131,693
$79.29 P/Share
|
|
Jan 19
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
5,000
-0.16%
|
$375,000
$75.07 P/Share
|
|
Jan 11
2021
|
Marijn E Dekkers |
SELL
Open market or private sale
|
Direct |
44,962
-27.9%
|
$2,203,138
$49.13 P/Share
|
|
Jan 11
2021
|
Marijn E Dekkers |
BUY
Exercise of conversion of derivative security
|
Direct |
44,962
+30.3%
|
$584,506
$13.73 P/Share
|
|
Jan 05
2021
|
Mark T. Roskey SVP, Strategic Partnerships |
SELL
Open market or private sale
|
Direct |
98
-0.45%
|
$4,312
$44.13 P/Share
|
|
Jan 05
2021
|
Dawn Mattoon Sr. VP, Diagnostics |
SELL
Open market or private sale
|
Direct |
170
-0.55%
|
$7,480
$44.13 P/Share
|
|
Jan 05
2021
|
E Kevin Hrusovsky Executive Chairman |
SELL
Open market or private sale
|
Direct |
3,510
-0.34%
|
$154,440
$44.13 P/Share
|
|
Jan 05
2021
|
John J Fry General Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
153
-0.48%
|
$6,732
$44.13 P/Share
|
|
Jan 05
2021
|
Amol Chaubal Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
124
-0.48%
|
$5,456
$44.13 P/Share
|
|
Jan 04
2021
|
Paul M Meister |
BUY
Grant, award, or other acquisition
|
Direct |
2,581
+8.63%
|
$56,782
$22.06 P/Share
|
|
Jan 04
2021
|
Martin D Madaus |
BUY
Grant, award, or other acquisition
|
Direct |
2,680
+8.37%
|
$58,960
$22.06 P/Share
|
|
Jan 04
2021
|
Keith Crandell |
BUY
Grant, award, or other acquisition
|
Direct |
2,467
+7.55%
|
$54,274
$22.06 P/Share
|
|
Jan 04
2021
|
Marijn E Dekkers |
BUY
Grant, award, or other acquisition
|
Direct |
2,270
+20.0%
|
-
|
|
Jan 04
2021
|
David R Walt |
BUY
Grant, award, or other acquisition
|
Direct |
2,270
+0.18%
|
-
|
|
Jan 04
2021
|
Sarah E. Hlavinka |
BUY
Grant, award, or other acquisition
|
Direct |
2,539
+9.72%
|
$55,858
$22.06 P/Share
|